Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Bulletin of the National Research Centre|April 18, 2022
COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variantsRashed Noor, Saadia Shareen, Muntasir Billah
Bulletin of the National Research Centre|July 20, 2022
Barotrauma and its complications in COVID-19 patients: a retrospective study at tertiary care hospital of Eastern IndiaRoopak Dubey, Kamal Kumar Sen, Aparajita Mishra
Bulletin of the National Research Centre|February 1, 2023
Marburg virus disease: the paradox of Nigeria's preparedness and priority effects in co-epidemicsRine Christopher Reuben, Sarah Adamma Abunike
Bulletin of the National Research Centre|April 28, 2021
Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severityRamakrishnan Veerabathiran, Barath Ragunath, Vaishak Kaviarasan, et al.
Bulletin of the National Research Centre|June 6, 2020
COVID-19 pandemic: a viewpoint from AsiaMd Abdullah-Al-Shafi
Bulletin of the National Research Centre|August 2, 2022
Protective and therapeutic potentials of HDL and ApoA1 in COVID-19 elderly and chronic illness patientsMohamed Aly AbdelHafez
Bulletin of the National Research Centre|May 26, 2021
Review of a controversial treatment method in the fight against COVID-19 with the example of AlgeriaHani Amir Aouissi, Mostefa Ababsa, Aissam Gaagai
Bulletin of the National Research Centre|August 9, 2021
SARS-CoV-2 infection: a global outbreak and its implication on public healthSankari Mohan, M Reshma Anjum, Anusha Kodidasu, et al.
Bulletin of the National Research Centre|October 25, 2021
Antibiotic resistance and ESBL production in Escherichia coli from various sources in Aba metropolis, NigeriaMartha Uzoaru Ajuga, Kome Otokunefor, Obakpororo Ejiro Agbagwa
Bulletin of the National Research Centre|July 12, 2022
From HIV to COVID-19, Molecular mechanisms of pathogens' trade-off and persistence in the community, potential targets for new drug developmentAntoine AbdelMassih, Abrar Sedky, Ahmed Shalaby, et al.
Pageof 11